Cerus Corporation (CERS): Price and Financial Metrics
Cerus Corporation (CERS)
Today's Latest Price: $5.01 USD
0.19 (3.94%)
Updated Apr 8 6:55pm
Add CERS to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
CERS Stock Summary
- With a price/sales ratio of 6.66, Cerus Corp has a higher such ratio than 87.49% of stocks in our set.
- With a year-over-year growth in debt of 115.77%, Cerus Corp's debt growth rate surpasses 87.57% of about US stocks.
- Revenue growth over the past 12 months for Cerus Corp comes in at 23.3%, a number that bests 79.62% of the US stocks we're tracking.
- If you're looking for stocks that are quantitatively similar to Cerus Corp, a group of peers worth examining would be MRAM, CSLT, PACB, JG, and NSTG.
- CERS's SEC filings can be seen here. And to visit Cerus Corp's official web site, go to www.cerus.com.
CERS Daily Price Range
CERS 52-Week Price Range
CERS Stock Price Chart More Charts
CERS Price/Volume Stats
| Current price | $5.01 | 52-week high | $6.64 |
| Prev. close | $4.82 | 52-week low | $2.71 |
| Day low | $4.84 | Volume | 2,198,400 |
| Day high | $5.25 | Avg. volume | 1,973,454 |
| 50-day MA | $4.60 | Dividend yield | N/A |
| 200-day MA | $4.74 | Market Cap | 812.45M |
Cerus Corporation (CERS) Company Bio
Cerus Corporation operates as a biomedical products company which focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The company was founded in 1991 and is based in Concord, California.
Top Stories View All
Top 3 Retailers This Earnings Season: WMT, DG, and ROST
Best & Worst Performing Stock Industries for April 8, 2020
Best & Worst Performing Small Cap Stocks for April 8, 2020
Best & Worst Performing Mid Cap Stocks for April 8, 2020
Best & Worst Performing Large Cap Stocks for April 8, 2020
View All Top Stories
Loading social stream, please wait...